NO174929C - Fremgangsmåte for fremstilling av et lett opplöselig konsentrat av trombinkoagulerbare proteiner - Google Patents

Fremgangsmåte for fremstilling av et lett opplöselig konsentrat av trombinkoagulerbare proteiner

Info

Publication number
NO174929C
NO174929C NO883342A NO883342A NO174929C NO 174929 C NO174929 C NO 174929C NO 883342 A NO883342 A NO 883342A NO 883342 A NO883342 A NO 883342A NO 174929 C NO174929 C NO 174929C
Authority
NO
Norway
Prior art keywords
thrombin
preparation
readily soluble
soluble concentrate
coagulable proteins
Prior art date
Application number
NO883342A
Other languages
English (en)
Norwegian (no)
Other versions
NO174929B (no
NO883342L (no
NO883342D0 (no
Inventor
Myriana Burnouf
Thierry Burnouf
Original Assignee
Centre Regional De Transfusion
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre Regional De Transfusion filed Critical Centre Regional De Transfusion
Publication of NO883342D0 publication Critical patent/NO883342D0/no
Publication of NO883342L publication Critical patent/NO883342L/no
Publication of NO174929B publication Critical patent/NO174929B/no
Publication of NO174929C publication Critical patent/NO174929C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/10—Polypeptides; Proteins
    • A61L24/106—Fibrin; Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A61K38/363—Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
NO883342A 1987-07-30 1988-07-28 Fremgangsmåte for fremstilling av et lett opplöselig konsentrat av trombinkoagulerbare proteiner NO174929C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8710798A FR2618784B1 (fr) 1987-07-30 1987-07-30 Concentre de proteines coagulables par la thrombine, son procede d'obtention et son utilisation a titre de colle biologique

Publications (4)

Publication Number Publication Date
NO883342D0 NO883342D0 (no) 1988-07-28
NO883342L NO883342L (no) 1989-01-31
NO174929B NO174929B (no) 1994-04-25
NO174929C true NO174929C (no) 1994-08-03

Family

ID=9353711

Family Applications (1)

Application Number Title Priority Date Filing Date
NO883342A NO174929C (no) 1987-07-30 1988-07-28 Fremgangsmåte for fremstilling av et lett opplöselig konsentrat av trombinkoagulerbare proteiner

Country Status (10)

Country Link
EP (1) EP0305243B1 (de)
JP (1) JP2787317B2 (de)
AT (1) ATE73341T1 (de)
CA (1) CA1341376C (de)
DE (1) DE3869018D1 (de)
DK (1) DK173568B1 (de)
ES (1) ES2039666T3 (de)
FR (1) FR2618784B1 (de)
GR (1) GR3004047T3 (de)
NO (1) NO174929C (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0431072Y2 (de) * 1988-03-14 1992-07-27
FR2639958B1 (fr) * 1988-12-06 1992-08-21 Lille Transfusion Sanguine Support biologique pour cultures cellulaires constitue de proteines plasmatiques coagulees par la thrombine, son utilisation pour la culture des keratinocytes, leur recuperation et leur transport a des fins d'utilisation therapeutique
US6197325B1 (en) 1990-11-27 2001-03-06 The American National Red Cross Supplemented and unsupplemented tissue sealants, methods of their production and use
US6117425A (en) 1990-11-27 2000-09-12 The American National Red Cross Supplemented and unsupplemented tissue sealants, method of their production and use
US7229959B1 (en) 1990-11-27 2007-06-12 The American National Red Cross Supplemented fibrin matrix delivery systems
US6054122A (en) 1990-11-27 2000-04-25 The American National Red Cross Supplemented and unsupplemented tissue sealants, methods of their production and use
DE4202667C1 (de) * 1992-01-29 1993-05-13 Behringwerke Ag, 3550 Marburg, De
WO1994002183A1 (en) * 1992-07-27 1994-02-03 Haemacure Biotech Inc. Biocompatible surgical implant
FR2696095B1 (fr) * 1992-09-30 1994-11-25 Inoteb Colle biologique à base de protéines coagulables par la thrombine, enrichie en facteurs plaquettaires, sa préparation et son application.
US5395923A (en) * 1993-02-23 1995-03-07 Haemacure-Biotech, Inc. Process for the obtention of a biological adhesive made of concentrated coagulation factors by "salting-out"
US5290918A (en) * 1993-02-23 1994-03-01 Haemacure Biotech Inc. Process for the obtention of a biological adhesive made of concentrated coagulation factors by acidic precipitation
DE69734557T2 (de) 1996-03-15 2006-07-27 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute Sprühvorrichtung zum aufbringen von gewebeklebstoff
WO1998055140A1 (en) * 1997-06-05 1998-12-10 Omrix Biopharmaceuticals S.A. Fibrinogen concentrate from human plasma
GB0216001D0 (en) 2002-07-10 2002-08-21 Nat Blood Authority Process and composition
US20060019234A1 (en) * 2004-07-22 2006-01-26 Shanbrom Technologies, Llc Modern blood banking employing improved cell preservation composition
FR2887883B1 (fr) * 2005-06-29 2007-08-31 Lab Francais Du Fractionnement Procede de separation des proteines fibrinogene, facteur xiii et colle biologique d'une fraction plasmatique solubilisee et de preparation de concentres lyophilises desdites proteines
FR2894831B1 (fr) 2005-12-16 2008-02-15 Lab Francais Du Fractionnement Colle biologique exempte de thrombine et son utilisation comme medicament.
FR2952641B1 (fr) 2009-11-18 2012-01-13 Lfb Biomedicaments Procede de traitement du plasma sanguin comprenant une etape de lavage par dispersion
FR3032621A1 (fr) 2015-02-13 2016-08-19 Lab Francais Du Fractionnement Colle biologique et son utilisation comme medicament
WO2016198641A1 (en) 2015-06-12 2016-12-15 Laboratoire Francais Du Fractionnement Et Des Biotechnologies Injectable composition of factor vii and fillers
JP7645133B2 (ja) * 2021-06-04 2025-03-13 Ｋｍバイオロジクス株式会社 血液凝固第ｘｉｉｉ因子を含むフィブリノゲンの製造方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4156681A (en) * 1974-03-28 1979-05-29 Plasmesco Ag Process for isolating albumin from blood
AT359653B (de) * 1979-02-15 1980-11-25 Immuno Ag Verfahren zur herstellung eines gewebekleb- stoffes
AT359652B (de) * 1979-02-15 1980-11-25 Immuno Ag Verfahren zur herstellung eines gewebekleb- stoffes
DE3175003D1 (en) * 1981-06-25 1986-08-28 Serapharm Gmbh & Co Kg Enriched plasma derivative for promoting wound sealing and wound healing
US4374061A (en) * 1981-07-27 1983-02-15 Center For Blood Research, Inc. Means and methods for purifying Clq, Clr and Cls
DE3203775A1 (de) * 1982-02-04 1983-08-11 Behringwerke Ag, 3550 Marburg Fibrinogenzubereitung, verfahen zu ihrer herstellungund ihre verwendung
DE3228502A1 (de) * 1982-07-30 1984-02-02 Behringwerke Ag, 3550 Marburg Verfahren zur herstellung des c1-inaktivators und seine verwendung
US4540573A (en) * 1983-07-14 1985-09-10 New York Blood Center, Inc. Undenatured virus-free biologically active protein derivatives
AT389815B (de) * 1984-03-09 1990-02-12 Immuno Ag Verfahren zur inaktivierung von vermehrungsfaehigen filtrierbaren krankheitserregern in blutprodukten
US4613501A (en) * 1984-12-21 1986-09-23 New York Blood Center, Inc. Inactivation of viruses in labile blood derivatives

Also Published As

Publication number Publication date
ATE73341T1 (de) 1992-03-15
FR2618784B1 (fr) 1990-04-06
DE3869018D1 (de) 1992-04-16
ES2039666T3 (es) 1993-10-01
DK424188A (da) 1989-01-31
EP0305243A1 (de) 1989-03-01
EP0305243B1 (de) 1992-03-11
JP2787317B2 (ja) 1998-08-13
NO174929B (no) 1994-04-25
DK173568B1 (da) 2001-03-19
DK424188D0 (da) 1988-07-29
JPH02114A (ja) 1990-01-05
CA1341376C (fr) 2002-07-16
GR3004047T3 (de) 1993-03-31
NO883342L (no) 1989-01-31
NO883342D0 (no) 1988-07-28
FR2618784A1 (fr) 1989-02-03

Similar Documents

Publication Publication Date Title
NO174929C (no) Fremgangsmåte for fremstilling av et lett opplöselig konsentrat av trombinkoagulerbare proteiner
ATE159297T1 (de) Expression von menschlichen serumalbumin in methylotrophischen hefen
DE58909191D1 (de) Thermoplastisch verarbeitbare stärke sowie verfahren zu deren herstellung.
CA2263337A1 (en) Process for the formation of plasticized proteinaceous materials, and compositions containing the same
DE3876401D1 (de) N-terminale fragmente von menschlichem serumalbumin.
NO905264L (no) Fremgangsmaate for fremstilling av biologisk aktivt protein
DE3580283D1 (de) Biologisch wirksame substanz mit hormonellen eigenschaften, verfahren zu ihrer herstellung und verwendung von histonen fuer medizinische zwecke.
DE3586346D1 (de) Mikrobielle herstellung von propionsaeure in mischkultur.
NO891921D0 (no) Ekspresjon av s- og pres2- proteiner av hepatitt b i metylotrof gjaer.
ATE94070T1 (de) Faktor xiii zur vorbeugung von intraventrikulaeren blutungen.
AU567747B2 (en) Early detection of mammalian pregnancy
NO951407D0 (no) Interdigiterings-kondensasjonsliposomer og geler
DE69012650D1 (de) Piperidinderivat, Verfahren zur Herstellung davon und dieses enthaltende pharmazeutische Zusammensetzung.
DE69024244D1 (de) Verfahren zur Herstellung von supraleitendem Material auf Bismuth-Basis
DE69018755D1 (de) Verfahren zur Herstellung von 3-(L-Pyroglutamyl)-L-thiazolidin-4-carbonsäure-Derivaten.
EP0510086A4 (en) Interdigitation-fusion liposomes and gels
DE68923496D1 (de) Verfahren zur Herstellung von motilinähnlichen Polypeptiden und seine Expression.
DE3888887D1 (de) Monoklonale Antikörper gegen E7-Protein des Humanen Papillomvirus Typ 16, Verfahren zu ihrer Herstellung sowie ihre Verwendung.
DE59605774D1 (de) Verfahren zur Herstellung von beta-Carotin-Präparaten mit hohem 9(Z)-Gehalt
ATE92308T1 (de) Verfahren zur herstellung einer festen zusammensetzung von lactulose.
NO894363D0 (no) Fremgangsmaate for fremstilling av et insulinforprodukt i streptomyceter.
DE69020627D1 (de) Supraleitende Einrichtung mit drei Anschlüssen und Prozess für deren Herstellung.
DE68912164D1 (de) Verfahren zur Herstellung eines organischen polykristallin Materials mit insbesondere elektro-optischen Eigenschaften.
EP0424996A3 (en) Acid hydrolysis process of vegetable proteins for producing a proteinous extract with low content in 3-monochloropropandiol and 1,2-dichloropropanol in not detectable amount
CA2170600A1 (en) Wound covering material and wound covering composition

Legal Events

Date Code Title Description
MK1K Patent expired